Target intelligence / Profile preview

POU class 3 homeobox 3 (POU3F3)

Target
POU3F3
Molecular classification
Transcription factor, Homeobox protein, DNA-binding protein
01

Overview

POU class 3 homeobox 3 (POU3F3) is a transcription factor encoded by the POU3F3 gene, which features two functional domains (POU-specific and homeobox domains) critical for sequence-specific DNA binding. It is most active during neural development, regulating cortical neuron migration, layer specification, and neurogenesis by binding to octamer motifs in the promoters/enhancers of target genes[1][3][4][5][6][7]. Pathogenic variants in POU3F3 cause Snijders Blok-Fisher Syndrome, a rare neurodevelopmental disorder marked by delayed speech, global developmental delay, intellectual disability, autistic features, epilepsy, hypotonia, dysmorphic features, and other comorbidities (e.g., hearing loss, ophthalmological anomalies, joint hypermobility)[3][8]. POU3F3 is not a direct target for therapeutic drugs but serves as a crucial developmental regulator whose dysfunction leads to a spectrum of neurodevelopmental disorders.

Other names
BRN1OTF8Brain-1Brn-1Oct-8OTF-8brain-specific homeobox/POU domain protein 1octamer-binding protein 8octamer-binding transcription factor 8SNIBFISbrain-1oct-8
02

Biological functions

Regulation of neuronal developmentCortical neuronal migrationSpecification and production of upper-layer cortical neuronsNeurogenesisDNA sequence-specific binding (recognition of octamer motifs)
03

Disease associations

Neurodevelopmental disorders (specifically Snijders Blok-Fisher Syndrome; OMIM #618604)Autism spectrum disorder (ASD)EpilepsyIntellectual disabilityMelanoma (reported association)

Beyond the preview

Go deeper on POU class 3 homeobox 3 (POU3F3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU class 3 homeobox 3 (POU3F3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call